1. Modified bi‐weekly cetuximab‐cisplatin and 5‐FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients. Issue 3 (28th June 2021) Authors: Meirovitz, Amichay; Bergerson, Shani; Hirshoren, Nir; Weinberger, Jeffrey M.; Bersudski, Evgeniya; Daniel, Sharon; Sheva, Kim; Perez, Cesar A. Journal: Cancer reports Issue: Volume 5:Issue 3(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗